Sodium glucose co-transport 2 inhibitors in the treatment of type 2 diabetes mellitus: a meta-analysis of randomized double-blind controlled trials

@inproceedings{Berhan2013SodiumGC,
  title={Sodium glucose co-transport 2 inhibitors in the treatment of type 2 diabetes mellitus: a meta-analysis of randomized double-blind controlled trials},
  author={Asres Berhan and Alex J Barker},
  booktitle={BMC endocrine disorders},
  year={2013}
}
BACKGROUND The discovery of sodium-glucose co-transporter 2 (SGLT2) inhibitors, with a novel mechanism independent of insulin secretion or sensitization, bring about a new therapeutic approach to the management of type 2 diabetes mellitus. The aim of this meta-analysis was to evaluate the safety and efficacy of SGLT2 inhibitors at different doses in randomized double blind clinical trials. METHODS This meta-analysis was conducted by including randomized double-blind controlled trials of SGLT2… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 41 references

Diabetes: successes and opportunities for population-based prevention and control: at a glance 2011

  • Centers for Disease Control, Prevention
  • Avalilable from: URL: http://www.cdc.gov…
  • 2013
1 Excerpt

Similar Papers

Loading similar papers…